109 related articles for article (PubMed ID: 19353339)
21. European Guidelines for Quality Assurance in Cervical Cancer Screening. Europe against cancer programme.
Coleman D; Day N; Douglas G; Farmery E; Lynge E; Philip J; Segnan N
Eur J Cancer; 1993; 29A Suppl 4():S1-38. PubMed ID: 8274301
[No Abstract] [Full Text] [Related]
22. Early diagnosis of cervical cancers. Our experience at the Rural Cancer Registry, Barshi, India.
Jayant K; Rao RS; Nene BM; Dale PS
Indian J Cancer; 1994 Jun; 31(2):59-63. PubMed ID: 7927450
[TBL] [Abstract][Full Text] [Related]
23. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
[TBL] [Abstract][Full Text] [Related]
24. The use of cervical screening history data to interpret cervical cancer incidence trends.
Clare J; Edwards D; Bagnall H; Pearmain P; Lawrence G
J Public Health (Oxf); 2008 Jun; 30(2):171-7. PubMed ID: 18296455
[TBL] [Abstract][Full Text] [Related]
25. Cervical mass screening in Norway--510,000 smears a year.
Bjørge T; Gunbjørud AB; Langmark F; Skare GB; Thoresen SO
Cancer Detect Prev; 1994; 18(6):463-70. PubMed ID: 7867019
[TBL] [Abstract][Full Text] [Related]
26. Study of completeness of the surveillance, epidemiology and end results (SEER) program case ascertainment by hospital size and casefinding source.
Zippin C; Lum D
Health Rep; 1993; 5(1):87-90. PubMed ID: 8334243
[TBL] [Abstract][Full Text] [Related]
27. The Swedish Heart Surgery Register: data quality for proximal thoracic aortic operations.
Olsson C; Eriksson N; Ståhle E; Thelin S
Scand Cardiovasc J; 2006 Dec; 40(6):348-53. PubMed ID: 17118825
[TBL] [Abstract][Full Text] [Related]
28. [Cervical cancer in Bas-Rhin: trend and prediction of the incidence in 2014].
Eilstein D; Hédelin G; Schaffer P
J Gynecol Obstet Biol Reprod (Paris); 2002 Feb; 31(1):28-33. PubMed ID: 11976574
[TBL] [Abstract][Full Text] [Related]
29. [Cervical cancer after 10 years of nationally coordinated screening].
Haldorsen T; Skare GB; Steen R; Thoresen SO
Tidsskr Nor Laegeforen; 2008 Mar; 128(6):682-5. PubMed ID: 18337847
[TBL] [Abstract][Full Text] [Related]
30. Geographic & age variations in invasive cervical cancer in Kentucky, 1995-1999.
Wyatt S; Ross FE; Bottorff D; Lancaster M
J Ky Med Assoc; 2002 Oct; 100(10):441-6. PubMed ID: 12395746
[TBL] [Abstract][Full Text] [Related]
31. Low proportion of unreported cervical treatments in the cancer registry of Norway between 1998 and 2013.
Leinonen MK; Hansen SA; Skare GB; Skaaret IB; Silva M; Johannesen TB; Nygård M
Acta Oncol; 2018 Dec; 57(12):1663-1670. PubMed ID: 30169991
[TBL] [Abstract][Full Text] [Related]
32. Risk of invasive cervical cancer in relation to management of abnormal Pap smear results.
Silfverdal L; Kemetli L; Andrae B; Sparén P; Ryd W; Dillner J; Strander B; Törnberg S
Am J Obstet Gynecol; 2009 Aug; 201(2):188.e1-7. PubMed ID: 19560117
[TBL] [Abstract][Full Text] [Related]
33. Cervical cancer screening programs. I. Epidemiology and natural history of carcinoma of the cervix.
Can Med Assoc J; 1976 Jun; 114(11):1003-12. PubMed ID: 776378
[No Abstract] [Full Text] [Related]
34. Declining use of radiotherapy for invasive cervical cancer in Connecticut: 1983-1990.
Polednak AP
Gynecol Oncol; 1995 Aug; 58(2):226-9. PubMed ID: 7622109
[TBL] [Abstract][Full Text] [Related]
35. Comparison of recorded medication use in the Medical Birth Registry of Norway with prescribed medicines registered in the Norwegian Prescription Database.
Espnes MG; Bjørge T; Engeland A
Pharmacoepidemiol Drug Saf; 2011 Mar; 20(3):243-8. PubMed ID: 21351305
[TBL] [Abstract][Full Text] [Related]
36. [Danish Quality Database for Cervical Cancer Screening].
Rygaard C
Ugeskr Laeger; 2012 Oct; 174(42):2534. PubMed ID: 23079437
[No Abstract] [Full Text] [Related]
37. Amended reports: when, if ever?
Davey DD
Diagn Cytopathol; 1997 Dec; 17(6):399-400. PubMed ID: 9407194
[No Abstract] [Full Text] [Related]
38. Quality of prostate cancer data in the cancer registry of Norway.
Harvei S; Tretli S; Langmark F
Eur J Cancer; 1996 Jan; 32A(1):104-10. PubMed ID: 8695215
[TBL] [Abstract][Full Text] [Related]
39. Comparison of data from the Norwegian Patient Register and the Cancer Registry of Norway.
Bakken IJ; Gystad SO; Christensen ØO; Huse UE; Larønningen S; Nygård J; Holmstrøm L; Johannesen TB; Møller B; Larsen IK
Tidsskr Nor Laegeforen; 2012 Jun; 132(11):1336-40. PubMed ID: 22717858
[TBL] [Abstract][Full Text] [Related]
40. Recommended code of practice for laboratories providing a cytopathology service 1997. British Society for Clinical Cytology.
Cytopathology; 1997 Jun; 8 Suppl 1():1-25. PubMed ID: 9202905
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
